insights_auto
Why is CADL up 2.30%?
Dive Deeperchevron_right
CADL:NASDAQ
Candel Therapeutics Inc
$11.55
arrow_upward
+2.30%(+0.26) 1D
$11.31
arrow_downward
-2.08% (-0.24)bedtimeAfter hours
Closed: Sep 24, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CADL...
Open
$11.22
High
$12.01
Low
$10.85
Mkt. cap
883.79M
Avg. vol.
1.36M
Volume
883.11K
52-wk high
$14.00
52-wk low
$4.35
EPS
-$1.41
Beta
-0.48
Shares outstanding
76.52M
No. of employees
55
Open
$11.22
High
$12.01
Low
$10.85
Mkt. cap
883.79M
Avg. vol.
1.36M
Volume
883.11K
52-wk high
$14.00
52-wk low
$4.35
EPS
-$1.41
Beta
-0.48
Shares outstanding
76.52M
No. of employees
55
News stories
From web sources and news partners
Seeking Alpha
·
2 days ago
Candel Therapeutics: Strong Buy On Aglatimagene Prostate Cancer BLA Filing In Q4 (CADL)
About Candel Therapeutics Inc
CEO-
Employees55
Founded2003
HeadquartersNeedham, Massachusetts, United States
SectorBiotechnology
Websitecandeltx.com